August 11th 2025
NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.
Let’s Ask the Right Questions About Medical Aid in Dying
Some patients are intractably and maybe even irredeemably ill. What should be done for them?
Read More
A New Question in End-of-Life Ethics
Patients with terminal illnesses may choose to refuse treatment or even hasten their own deaths, but is that the same thing as suicide?
Read More